Your browser doesn't support javascript.
loading
Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
Tronieri, Jena S; Fabricatore, Anthony N; Wadden, Thomas A; Auerbach, Pernille; Endahl, Lars; Sugimoto, Danny; Rubino, Domenica.
Affiliation
  • Tronieri JS; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA, jena.tronieri@pennmedicine.upenn.edu.
  • Fabricatore AN; Novo Nordisk Inc., Plainsboro, New Jersey, USA.
  • Wadden TA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Auerbach P; Novo Nordisk A/S, Søborg, Denmark.
  • Endahl L; Novo Nordisk A/S, Søborg, Denmark.
  • Sugimoto D; Cedar Crosse Research Center, Chicago, Illinois, USA.
  • Rubino D; Washington Center for Weight Management and Research, Arlington, Virginia, USA.
Obes Facts ; 13(6): 572-583, 2020.
Article in En | MEDLINE | ID: mdl-33197917
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exercise / Anti-Obesity Agents / Diet / Liraglutide / Obesity Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Obes Facts Journal subject: METABOLISMO Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exercise / Anti-Obesity Agents / Diet / Liraglutide / Obesity Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Obes Facts Journal subject: METABOLISMO Year: 2020 Type: Article